Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 7.807
Filter
1.
J Drugs Dermatol ; 23(7): 567-568, 2024 Jul 01.
Article in English | MEDLINE | ID: mdl-38954615

ABSTRACT

We present a case of a patient with a 10-year history of blue-black macules and patches on the face and an associated history of skin-lightening cream usage. The skin lightening cream contained hydroquinone, which is often associated with exogenous ochronosis (EO). Interestingly, the biopsy did not show characteristic findings of ochronosis, confusing the final diagnosis, however discontinuing the skin-lightening creams halted the progression of the patient's skin lesions supporting a diagnosis of EO. EO presents as asymptomatic hyperpigmentation after using products containing hydroquinone. This condition is most common in Black populations, likely due to the increased use of skin care products and bleaching cream containing hydroquinone in these populations. Topical hydroquinone is FDA-approved to treat melasma, chloasma, freckles, senile lentigines, and hyperpigmentation and is available by prescription only in the US and Canada. However, with the increased use of skin-lightening creams in certain populations, it is important for dermatologists to accurately recognize the clinical features of exogenous ochronosis to differentiate it from similar dermatoses. An earlier diagnosis can prevent the progression to severe presentations with papules and nodules. We summarize the clinical presentations diagnostic features, and treatment pearls, concluding with a discussion of the differential diagnoses.  J Drugs Dermatol. 2024;23(7):567-568.     doi:10.36849/JDD.8248.


Subject(s)
Hydroquinones , Hyperpigmentation , Lichen Planus , Ochronosis , Humans , Ochronosis/diagnosis , Ochronosis/chemically induced , Hyperpigmentation/chemically induced , Hyperpigmentation/diagnosis , Hydroquinones/adverse effects , Hydroquinones/administration & dosage , Diagnosis, Differential , Lichen Planus/diagnosis , Lichen Planus/chemically induced , Lichen Planus/drug therapy , Female , Skin Lightening Preparations/adverse effects , Skin Lightening Preparations/administration & dosage , Facial Dermatoses/diagnosis , Facial Dermatoses/chemically induced , Facial Dermatoses/pathology , Facial Dermatoses/drug therapy , Middle Aged , Skin Cream/adverse effects , Skin Cream/administration & dosage
2.
Acta Derm Venereol ; 104: adv40091, 2024 Jul 02.
Article in English | MEDLINE | ID: mdl-38956961

ABSTRACT

Molluscum contagiosum is a common skin infection affecting different body areas, including the face. Previous data have shown cases of atypical lesions, notably on the face, and it was thought relevant to further examine differences between facial and non-facial lesions. All cases of children (0-18) diagnosed with molluscum contagiosum from 2013-2022 at the paediatric dermatology clinic of Soroka University Medical Center were retrospectively reviewed, and 615 children were included in the study. Facial lesions tended to be found in younger children (p = 0.018). Non-facial lesions were more erythematous (p < 0.001), itchier (p < 0.001), and showed similar patterns of ulceration (p = 0.078) and purulence (p = 0.779). The average lesion diameter was similar in patients with or without facial lesions (p = 1). Children with facial lesions were treated differently from patients without facial lesions (p < 0.001); however, there were no differences in treatment response. This research challenges assumptions concerning the severity of facial lesions, including eyelid lesions, by revealing that, overall, they exhibit less inflammation than non-facial lesions. Despite the potential for greater psychosocial burdens and impacts on self-esteem associated with lesions on the sensitive facial area, this study provides evidence that they are not inherently more worrisome and can be managed similarly to lesions found elsewhere in the body.


Subject(s)
Facial Dermatoses , Molluscum Contagiosum , Humans , Child , Child, Preschool , Female , Male , Retrospective Studies , Cross-Sectional Studies , Infant , Adolescent , Facial Dermatoses/virology , Infant, Newborn , Severity of Illness Index , Age Factors
3.
Mycoses ; 67(6): e13754, 2024 Jun.
Article in English | MEDLINE | ID: mdl-38880935

ABSTRACT

BACKGROUND: Tinea faciei is a relatively uncommon dermatophyte infection. The studies, which included clinical forms, and isolated species of dermatophytes, are limited. MATERIALS AND METHODS: This retrospective study aims to determine the causative organism, clinical characteristics, treatments and outcomes of patients with tinea faciei attending the dermatologic clinic, Siriraj Hospital, from 1 January 2017 to 30 September 2021. Demographic data, clinical presentations, isolated dermatophyte species, treatments and outcomes were collected and analysed. RESULTS: A total of 151 tinea faciei cases were observed. Trichophyton rubrum (48.6%), Trichophyton mentagrophytes complex (22.2%) and Microsporum canis (18.1%) were common causative agents. Tinea faciei was commonly detected in females (64.9%) with a history of pets (54.6%). Clinical presentations often involved plaques and scales on the cheeks. Among patients with lesions on the cheek, mycological cure was observed significantly less often compared to those without cheek lesions. Patients with other concurrent skin or nail infections, a history of topical steroids and a history of previous fungal infection had a slightly longer duration of mycological cure than those without factors. Recurrent infection was found in 33.3%. Male, history of previous fungal infection, and lesions on the cheeks were significantly associated with recurrent infection. CONCLUSIONS: Fungal infection of the face was commonly found in women and patients with pets. The most common pathogen that caused tinea faciei was T. rubrum. Topical antifungal treatments could be used with favourable outcomes. The history of past infection and lesion on the cheeks should be carefully assessed to be vigilant for recurrent infection.


Subject(s)
Antifungal Agents , Arthrodermataceae , Microsporum , Tinea , Humans , Retrospective Studies , Female , Male , Tinea/microbiology , Tinea/drug therapy , Tinea/epidemiology , Thailand/epidemiology , Adult , Antifungal Agents/therapeutic use , Middle Aged , Arthrodermataceae/isolation & purification , Arthrodermataceae/classification , Arthrodermataceae/drug effects , Young Adult , Adolescent , Microsporum/isolation & purification , Child , Treatment Outcome , Aged , Facial Dermatoses/microbiology , Facial Dermatoses/drug therapy , Child, Preschool
4.
Mycoses ; 67(6): e13755, 2024 Jun.
Article in English | MEDLINE | ID: mdl-38888369

ABSTRACT

BACKGROUND: Tinea faciei, a specific dermatophytosis that affects the glabrous skin of the face, not only causes physical discomfort but also leads to greater psychological distress. Tinea faciei is a public health concern. OBJECTIVES: To analyse the epidemiological characteristics, responsible dermatophyte species and clinical features of tinea faciei in Hangzhou. METHODS: Data were obtained from the Laboratory Information System of the Mycology Laboratory and Medical Information System at a hospital in Hangzhou. Isolates were identified based on their macroscopic appearance and microscopic morphology. RESULTS: Tinea faciei was diagnosed in 701 patients, involving 359 males and 342 females, aged between 2 months and 97 years. In total, 499 isolates (71.18%) were identified as Trichophyton rubrum. Anthropophilic isolates were identified in 297 (82.73%) males and 207 (60.53%) females (p < .01). Among patients with anthropophilic dermatophytes infection, 447 (88.69%) were adults. Zoophilic dermatophytes were isolated in 57 (15.88%) males and 130 (38.01%) females (p < .01), among whom 108 (57.75%) were children. CONCLUSIONS: Anthropophilic dermatophytes, especially T. rubrum, were the predominant cause of tinea faciei, while zoophilic dermatophytes were the most prevalent in children. Compared with men, women may be more susceptible to zoophilic dermatophytes.


Subject(s)
Arthrodermataceae , Tinea , Humans , Male , Female , Adolescent , China/epidemiology , Child , Tinea/microbiology , Tinea/epidemiology , Adult , Middle Aged , Child, Preschool , Young Adult , Infant , Aged , Arthrodermataceae/isolation & purification , Arthrodermataceae/classification , Aged, 80 and over , Facial Dermatoses/microbiology , Facial Dermatoses/epidemiology , Facial Dermatoses/pathology , Face/microbiology , Face/pathology , Surveys and Questionnaires
7.
Nihon Shokakibyo Gakkai Zasshi ; 121(6): 481-488, 2024.
Article in Japanese | MEDLINE | ID: mdl-38853017

ABSTRACT

Pyoderma gangrenosum (PG) is a sterile inflammatory skin condition that is frequently associated with immune-related diseases, including inflammatory bowel disease (IBD). PG causes noninfectious ulcers. Facial PG is uncommon while PG usually occurs on the trunk and lower limbs. Herein, we report a case of a male teenager with fever, pustules, ulcers, and necrosis on both cheeks. He was initially diagnosed with complicated acne with bacterial infection, but the condition progressed to subcutaneous ulcers despite treatment. Biopsy revealed inflammatory lesions in dermal and subcutaneous tissue with neutrophil infiltration, consistent with PG. Although lacking typical IBD symptoms, blood tests revealed anemia and positive fecal occult blood. Sigmoidoscopy revealed inflammation, ulcers, and pseudopolyps in the colon and rectum, thereby diagnosing ulcerative colitis (UC). After treating PG and UC with prednisolone and skin grafts, golimumab was prescribed. The patient is now in remission. Necrotic tissue buildup can complicate closure in PG cases;this emphasizes the need for effective IBD treatment to facilitate procedures such as skin grafts.


Subject(s)
Colitis, Ulcerative , Pyoderma Gangrenosum , Humans , Pyoderma Gangrenosum/diagnosis , Pyoderma Gangrenosum/drug therapy , Male , Colitis, Ulcerative/complications , Adolescent , Facial Dermatoses/etiology , Facial Dermatoses/drug therapy , Facial Dermatoses/diagnosis , Antibodies, Monoclonal/therapeutic use , Antibodies, Monoclonal/administration & dosage
11.
Lasers Surg Med ; 56(5): 466-473, 2024 07.
Article in English | MEDLINE | ID: mdl-38693708

ABSTRACT

OBJECTIVES: To investigate the efficacy of Fractional Radiofrequency Microneedling (FRM) in treating corticosteroid-induced facial erythema. METHODS: A retrospective study was conducted involving eight patients diagnosed as corticosteroid-induced facial erythema. Each patient underwent a single session of FRM. Evaluative measures included Clinician's Erythema Assessment (CEA), Patient's Self-Assessment (PSA), assessment of telangiectasia severity, procedure-associated pain (10-point scale), patient satisfaction (3-point scale) and secondary outcomes. RESULTS: The study found a 75% success rate and 100% effectiveness rate in alleviating erythema symptoms. CEA and PSA scores decreased by 67.7% and 78.1%, respectively. No cases of erythema rebound were recorded during the 3-month follow-up period. CONCLUSIONS: FRM demonstrated effectiveness and safety in treating facial erythema, offering promising advancement in dermatologic therapeutics.


Subject(s)
Erythema , Needles , Humans , Retrospective Studies , Female , Erythema/etiology , Erythema/therapy , Adult , Middle Aged , Male , Needles/adverse effects , Treatment Outcome , Radiofrequency Therapy/adverse effects , Facial Dermatoses/therapy , Adrenal Cortex Hormones/therapeutic use , Patient Satisfaction , Aged , Percutaneous Collagen Induction
15.
20.
Pediatr Dermatol ; 41(2): 243-246, 2024.
Article in English | MEDLINE | ID: mdl-38413004

ABSTRACT

BACKGROUND: Idiopathic aseptic facial granuloma (IAFG) is an underrecognized pediatric skin disease, currently considered within the spectrum of rosacea. It usually manifests as a solitary, reddish, asymptomatic nodule on the cheek that resolves spontaneously. METHODS: Retrospective and descriptive observational study of 43 pediatric patients with a clinical diagnosis of IAFG, followed between 2004 and 2022, at two general hospitals in Argentina. RESULTS: IAFG predominated in girls (65%) and the average age of onset was about 6 years. A single asymptomatic nodule was seen in 79% of patients. The most common localization was the cheek (58%) followed by lower eyelids (41%). Family history of rosacea was present in 16% of patients. A concomitant diagnosis of rosacea and periorificial dermatitis was made in 14% and 9% of our population, respectively. Past or present history of chalazia was detected in 42% of the children. IAFG diagnosis was mainly clinical (88% of cases). Oral antibiotics were the most common indicated treatment (84%). Complete healing was achieved by the majority, but 18% of those with eyelid compromise healed with scars. CONCLUSIONS: IAFG is a benign pediatric condition that physicians should recognize in order to manage correctly. We herein refer to a particular morphologic aspect of IAFG lesions affecting the lower eyelids, where nodules adopt a linear distribution and have a higher probability of involute leaving a scar. Also, we consider that the concomitant findings of rosacea, periorificial dermatitis and chalazia in our patients, reinforce the consideration of IAFG within the spectrum of rosacea.


Subject(s)
Chalazion , Connective Tissue Diseases , Dermatitis , Facial Dermatoses , Rosacea , Female , Humans , Child , Retrospective Studies , Chalazion/complications , Chalazion/diagnosis , Facial Dermatoses/diagnosis , Facial Dermatoses/drug therapy , Facial Dermatoses/pathology , Granuloma/diagnosis , Granuloma/drug therapy , Rosacea/diagnosis , Rosacea/drug therapy , Rosacea/epidemiology
SELECTION OF CITATIONS
SEARCH DETAIL
...